Osteoporosis caused by Glucocorticoid Treatment Active Not Recruiting Phase 3 Trials for Denosumab (DB06643)

Also known as: Glucocorticoid Induced Osteoporosis / Steroid-induced osteoporosis / Osteoporosis, Steroid Induced / Osteoporosis caused by glucocorticoid / Osteoporosis caused by corticosteroid / Osteoporosis steroid-induced / Glucocorticoid-induced Osteoporosis / Osteoporosis caused by corticosteroid (disorder) / Osteoporosis due to corticosteroids (disorder) / Osteoporosis / Osteoporosis (disorder) / Osteoporosis NOS (disorder) / Involutional osteoporosis without current pathological fracture / Osteoporosis, unspecified / Osteoporosis NOS / Osteoporosis, unspecified (disorder)

IndicationStatusPhase
DBCOND0129307 (Osteoporosis caused by Glucocorticoid Treatment)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03164928Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced OsteoporosisTreatment